Literature DB >> 2659969

Control of formation of active soluble or inactive insoluble baker's yeast alpha-glucosidase PI in Escherichia coli by induction and growth conditions.

E Kopetzki1, G Schumacher, P Buckel.   

Abstract

Using standard growth conditions (LB medium, 37 degrees C, induction with 5 mM IPTG) yeast alpha-glucosidase PI expressed under the control of the regulated tac-hybrid promoter results in the synthesis of insoluble aggregated alpha-glucosidase granules in Escherichia coli. Under these conditions active soluble alpha-glucosidase amounts to less than 1% of the heterologously produced protein. However, the amount of soluble active alpha-glucosidase was dramatically increased when the strong tac-hybrid promoter was to a limited extent induced. This was achieved at concentrations of 0.01 mM IPTG or of 1% lactose or lower in a lactose-permease deficient host strain containing the lacIq repressor gene on an R-plasmid. The formation of active soluble alpha-glucosidase was almost 100% when E. coli cells induced in this manner were cultivated under conditions that reduced growth rate, i.e. at decreased temperature, extreme pH values or in minimal and complete media supplemented with different carbon sources.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2659969     DOI: 10.1007/bf00332244

Source DB:  PubMed          Journal:  Mol Gen Genet        ISSN: 0026-8925


  23 in total

1.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

2.  Refolding and association of oligomeric proteins.

Authors:  R Jaenicke; R Rudolph
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

3.  The elongation rate of proteins of different molecular weight classes in yeast.

Authors:  C Waldron; R Jund; F Lacroute
Journal:  FEBS Lett       Date:  1974-09-15       Impact factor: 4.124

4.  Fate of abnormal proteins in E. coli accumulation in intracellular granules before catabolism.

Authors:  W F Prouty; A L Goldberg
Journal:  Nat New Biol       Date:  1972-11-29

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Expression of human lysozyme in an insoluble form in yeast.

Authors:  T Hayakawa; A Toibana; R Marumoto; K Nakahama; M Kikuchi; K Fujimoto; M Ikehara
Journal:  Gene       Date:  1987       Impact factor: 3.688

7.  Increased cell buoyant densities of protein overproducing Escherichia coli cells.

Authors:  Y S Cheng
Journal:  Biochem Biophys Res Commun       Date:  1983-02-28       Impact factor: 3.575

8.  High level expression of proinsulin in the yeast, Saccharomyces cerevisiae.

Authors:  L S Cousens; J R Shuster; C Gallegos; L L Ku; M M Stempien; M S Urdea; R Sanchez-Pescador; A Taylor; P Tekamp-Olson
Journal:  Gene       Date:  1987       Impact factor: 3.688

9.  Cloning and characterization of baker's yeast alpha-glucosidase: over-expression in a yeast strain devoid of vacuolar proteinases.

Authors:  E Kopetzki; P Buckel; G Schumacher
Journal:  Yeast       Date:  1989 Jan-Feb       Impact factor: 3.239

10.  Lactose permeation via the arabinose transport system in Escherichia coli K-12.

Authors:  A Messer
Journal:  J Bacteriol       Date:  1974-10       Impact factor: 3.490

View more
  15 in total

1.  Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli.

Authors:  U Rinas; J E Bailey
Journal:  Appl Microbiol Biotechnol       Date:  1992-08       Impact factor: 4.813

Review 2.  Approaches for the generation of active papain-like cysteine proteases from inclusion bodies of Escherichia coli.

Authors:  Chunfang Ling; Junyan Zhang; Deqiu Lin; Ailin Tao
Journal:  World J Microbiol Biotechnol       Date:  2015-03-20       Impact factor: 3.312

3.  Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography.

Authors:  Surianarayanan Bhuvanesh; Chakkaravarthi Arunkumar; Perumal Kaliraj; Subramanian Ramalingam
Journal:  J Ind Microbiol Biotechnol       Date:  2010-07-01       Impact factor: 3.346

4.  Mutational analysis of the active site of indoleglycerol phosphate synthase from Escherichia coli.

Authors:  B Darimont; C Stehlin; H Szadkowski; K Kirschner
Journal:  Protein Sci       Date:  1998-05       Impact factor: 6.725

5.  Comparison of small- and large-scale expression of selected Pyrococcus furiosus genes as an aid to high-throughput protein production.

Authors:  Frank J Sugar; Francis E Jenney; Farris L Poole; Phillip S Brereton; Michi Izumi; Claudia Shah; Michael W W Adams
Journal:  J Struct Funct Genomics       Date:  2005

6.  Quality control of inclusion bodies in Escherichia coli.

Authors:  Britta Jürgen; Antje Breitenstein; Vlada Urlacher; Knut Büttner; Hongying Lin; Michael Hecker; Thomas Schweder; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-28       Impact factor: 5.328

7.  Overexpression and simple purification of the Thermotoga maritima 6-phosphogluconate dehydrogenase in Escherichia coli and its application for NADPH regeneration.

Authors:  Yiran Wang; Y-H Percival Zhang
Journal:  Microb Cell Fact       Date:  2009-06-04       Impact factor: 5.328

8.  Stabilization of apoglobin by low temperature increases yield of soluble recombinant hemoglobin in Escherichia coli.

Authors:  M J Weickert; M Pagratis; S R Curry; R Blackmore
Journal:  Appl Environ Microbiol       Date:  1997-11       Impact factor: 4.792

9.  Periplasmic aggregation limits the proteolytic maturation of the Escherichia coli penicillin G amidase precursor polypeptide.

Authors:  S Scherrer; N Robas; H Zouheiry; G Branlant; C Branlant
Journal:  Appl Microbiol Biotechnol       Date:  1994-10       Impact factor: 4.813

10.  Overexpression of bacterial hemoglobin causes incorporation of pre-beta-lactamase into cytoplasmic inclusion bodies.

Authors:  U Rinas; J E Bailey
Journal:  Appl Environ Microbiol       Date:  1993-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.